By c.angulo, 18 June, 2019 IDMP FAQ The Working Group on Identification of Medicinal Products (IDMP) has published a Frequently Asked Questions (FAQ) document to address questions relate
By c.angulo, 14 June, 2019 IPRP - 3rd Meeting - Public Statement The third meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 2nd and 3rd of June 2019 i
By c.angulo, 7 February, 2019 New templates from the BEWGG To complement the template developed by the BEWGG for Biopharmaceutics Classification System (BCS) Biowaivers Assessment Reports, a template for Biowa
By c.angulo, 12 December, 2018 Reflection Paper from the Cell Therapy WG IPRP Reflection Paper General Principles to Address the Nature and Duration of Follow-up for Subjects of Clinical Trials Using Cell Therapy Produc
By c.angulo, 6 December, 2018 IPRP Stakeholder Engagement Plan While maintaining its focus as a forum for regulators to share best practices and experiences, IPRP is also committed to engage with its external stak
By c.angulo, 21 November, 2018 IPRP - 2nd Meeting - Public Statement The second meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committe (MC) was held on the 11th and 12th of November